DeepMed Research

Arkansas State University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1909-01-01

Employees: 251

Market Cap: -

Website: http://www.astate.edu

Clinical Trials

Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer

Phase 1

Withdrawn

Conditions: Carcinoma, Non-Small-Cell-Lung

First Posted Date: 2012-07-11

Last Posted Date: 2014-01-15

Lead Sponsor: University of Arkansas

Registration Number: NCT01637376

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth

Phase 2

Terminated

Conditions: Colorectal Neoplasms

Interventions: Drug: Placebo
Drug: Metformin

First Posted Date: 2012-06-29

Last Posted Date: 2016-07-11

Lead Sponsor: University of Arkansas

Target Recruit Count: 7

Registration Number: NCT01632020

Locations: 🇺🇸
Central Arkansas Veterans Heathcare System, Little Rock, Arkansas, United States
🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

Completed

Conditions: Multiple Myeloma

First Posted Date: 2012-06-19

Last Posted Date: 2015-03-03

Lead Sponsor: University of Arkansas

Target Recruit Count: 796

Registration Number: NCT01622582

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients

Withdrawn

Conditions: Aspergillosis
Candidemia
C. Difficile

First Posted Date: 2012-06-19

Last Posted Date: 2015-10-27

Lead Sponsor: University of Arkansas

Registration Number: NCT01622595

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma

Phase 3

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Revlimid

First Posted Date: 2012-06-18

Last Posted Date: 2015-10-19

Lead Sponsor: University of Arkansas

Target Recruit Count: 42

Registration Number: NCT01621672

Locations: 🇺🇸
University of Arkansas for Medical Science-MIRT, Little Rock, Arkansas, United States

Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Device: Active Repetitive Transcranial Magnetic Stimulation 1 Hz
Device: Sham control site Repetitive Transcranial Magnetic Stimulation
Device: Active Repetitive Transcranial Magnetic Stimulation 10 Hz
Device: Active control site Repetitive Transcranial Magnetic Stimulation at 1Hz
Device: Active control site Repetitive Transcranial Magnetic Stimulation at 10 Hz

First Posted Date: 2012-06-15

Last Posted Date: 2016-10-31

Lead Sponsor: University of Arkansas

Target Recruit Count: 26

Registration Number: NCT01620086

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

A Folinic Acid Intervention for Autism Spectrum Disorders

Phase 2

Terminated

Conditions: Autism Spectrum Disorder
Asperger's Syndrome
Autistic Disorder
Autism
Pervasive Development Disorders

Interventions: Drug: Folinic Acid and placebo
Drug: Folinic Acid

First Posted Date: 2012-05-18

Last Posted Date: 2017-10-17

Lead Sponsor: University of Arkansas

Target Recruit Count: 99

Registration Number: NCT01602016

Locations: 🇺🇸
Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States

Effects of a Breakfast and Snack on Cognitive Function in Preadolescents

Withdrawn

Conditions: Brain Function

First Posted Date: 2012-05-07

Last Posted Date: 2014-02-12

Lead Sponsor: University of Arkansas

Registration Number: NCT01592487

Locations: 🇺🇸
Arkansas Children's Nutrition Center, Little Rock, Arkansas, United States

Clinical Efficacy of Atomoxetine for Methamphetamine Dependence

Phase 1

Completed

Conditions: Methamphetamine Dependence

Interventions: Drug: placebo
Drug: Atomoxetine

First Posted Date: 2012-03-19

Last Posted Date: 2017-02-09

Lead Sponsor: University of Arkansas

Target Recruit Count: 20

Registration Number: NCT01557569

Locations: 🇺🇸
UAMS, Psychiatric Research Institute, Center for Addiction Research, Little Rock, Arkansas, United States

Walnut Oral Immunotherapy for Tree Nut Allergy

Phase 1

Completed

Conditions: Tree Nut Allergy

Interventions: Drug: Oat Powder (placebo)
Drug: Walnut Protein Powder
Drug: Open-label Walnut Protein Powder

First Posted Date: 2012-03-07

Last Posted Date: 2023-05-12

Lead Sponsor: University of Arkansas

Target Recruit Count: 22

Registration Number: NCT01546753

Locations: 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy